Magnesium Oxide: Benefits, Side Effects, Dosage, and ...

Please visit our website for more information on this topic.

Magnesium oxide is a supplement often used to treat migraine and constipation. It may provide other health benefits, including potentially lowering blood pressure and blood sugar levels.

Magnesium is a mineral that&#;s needed for many bodily processes, including blood sugar regulation, nerve function, energy production, and DNA synthesis (1).

It&#;s found in a number of foods but can also be taken as a dietary supplement. These supplements contain different forms of magnesium, including magnesium citrate, magnesium glycinate, and magnesium oxide.

Magnesium oxide is one of the most common forms sold in supplement form, either as a stand-alone supplement or in multinutrient products.

This article explains everything you need to know about magnesium oxide, including how it compares with other forms of magnesium, its potential benefits and side effects, and how to take it.

What is magnesium oxide?

Magnesium oxide is an inorganic salt of magnesium formed with ions of magnesium and oxygen (2).

It&#;s one of many forms of magnesium available for purchase in supplement form. It&#;s added to dietary supplements as well as over-the-counter medications used to treat constipation, indigestion, and headaches.

Compared with other forms of magnesium, it may be less effective at raising blood magnesium levels (3).

How does it compare with other forms of magnesium?

Magnesium oxide and other inorganic salts of magnesium like magnesium carbonate are high in elemental magnesium, which is the total amount of magnesium in a supplement (3).

However, they have a low solubility rate, making them less bioavailable than other forms of the mineral. So, even though magnesium oxide supplements provide a good amount of magnesium, it&#;s not the most available form for your body to utilize (3).

A study confirmed this by testing 15 magnesium supplements and finding that a supplement containing only magnesium oxide had the lowest bioavailability (3).

Meanwhile, a supplement with both inorganic and organic magnesium salts &#; magnesium oxide and magnesium glycerophosphate, respectively &#; had the highest bioavailability (3).

Because of its low absorption rate in your intestines, magnesium oxide may lead to digestive effects like diarrhea. In fact, its strong laxative effects are why it&#;s commonly used to treat constipation (3).

A rat study demonstrated its low absorption rate, concluding that only 15% of orally administered magnesium oxide was absorbed, while 85% was excreted in the feces. Older research suggests the absorption rate is even lower in humans (4, 5).

In contrast, magnesium citrate, magnesium acetyl taurate, magnesium malate, and magnesium glycinate all have high absorption rates and are more effective at increasing magnesium levels in the body (6, 7, 8, 9, 10).

Still, magnesium oxide has been shown to offer several benefits and is commonly used to treat medical conditions like chronic constipation.

Summary

Magnesium oxide is an inorganic salt of magnesium. Even though it contains high amounts of magnesium, it has low absorbability in the body. Still, it has been shown to offer health benefits like constipation relief.

Does it provide health benefits?

Research shows that magnesium oxide is effective at treating certain medical conditions.

May help treat headaches

Magnesium is needed for proper nerve cell functioning. As such, a deficiency in this mineral can lead to migraine headaches.

Studies show that magnesium oxide may reduce headache symptoms. It may even be as effective as some migraine headache medications (11).

For example, a randomized, controlled, double-blind study in 63 people who experienced migraine found that taking 500 mg of magnesium oxide daily reduced migraine frequency as effectively as a migraine medication called valproate sodium (12).

Older research also suggests that magnesium oxide may reduce migraine in children (13).

However, other forms of magnesium like magnesium sulfate and magnesium citrate may be more effective at treating migraine, as they are typically better absorbed (14, 15, 16).

May reduce stress and anxiety

Magnesium plays an important role in your body&#;s stress response. In fact, studies have shown that people who experience frequent stress tend to have lower magnesium stores (17).

Some studies have shown that supplementing with magnesium may help reduce levels of stress and anxiety in certain populations.

For example, a review of 18 studies found that magnesium oxide may reduce stress and anxiety in women with premenstrual syndrome, but only when combined with vitamin B6 (18).

Despite these promising results, researchers acknowledge that the quality of existing studies on the subject is poor, and future well-designed studies are needed (18).

Helps treat constipation

One of the most common uses of magnesium oxide supplements is constipation treatment. The supplement has an osmotic effect, meaning it draws water into the intestines to cause a laxative effect that can help relieve constipation in both children and adults.

In a small randomized, double-blind, controlled study, 34 women with mild to moderate constipation were treated with either 1.5 grams of magnesium oxide or a placebo daily for 4 weeks (19).

Many women in the magnesium group experienced significantly improved bowel movement frequency, stool form, colonic transport time, and quality of life compared with the placebo group (19).

In fact, over 70% of those treated with magnesium oxide reported overall symptom improvement, compared with only 25% of those in the placebo group (19).

Similarly, a study in 90 people with constipation found that taking either 1.5 grams of magnesium oxide or 1 gram of senna, another laxative, significantly improved spontaneous bowel movements and constipation-related quality of life compared with a placebo (20).

Magnesium oxide has also been shown to prevent constipation after surgery, treat opioid-induced constipation, and improve functional constipation in children (21).

That said, while magnesium oxide has been shown to be safe for treating constipation, it may lead to dangerously high magnesium levels in certain populations, such as those with kidney impairment and older adults (5).

May lower blood pressure

Magnesium oxide supplements may help reduce elevated blood pressure levels.

A study in 48 people with high blood pressure found that treatment with 300 mg of magnesium oxide per day for 1 month significantly decreased both systolic (the top number) and diastolic (the bottom number) blood pressure (23).

Researchers theorize that the supplement may lower blood pressure by decreasing cellular calcium levels to relax smooth muscle cells and widen blood vessels (23).

May lower blood sugar levels

Magnesium supplements may lower blood sugar levels in people with diabetes.

For example, supplements containing magnesium oxide and zinc have been shown to lower blood sugar levels in people with type 1 diabetes, type 2 diabetes, and gestational diabetes, which is diabetes that can occur during pregnancy (24).

In a study, 70 women with gestational diabetes supplemented with either 250 mg of magnesium oxide or a placebo daily for 6 weeks (25).

The magnesium oxide treatment significantly improved blood sugar levels. It also reduced triglyceride levels and the inflammatory markers C-reactive protein (CRP) and malondialdehyde, compared with the placebo group (25).

Magnesium oxide supplements have also been shown to improve blood sugar management in Egyptian children with type 1 diabetes and Iranian adults with type 2 diabetes (26, 27).

If you are looking for more details, kindly visit Meishen.

Summary

Magnesium oxide may help treat migraine and constipation, reduce blood pressure, improve blood sugar management, and decrease levels of stress and anxiety in certain populations.

Potential side effects and drug interactions 

While supplementing with magnesium oxide may offer some benefits, there are potential side effects to consider.

Magnesium oxide is generally safe when used in appropriate doses. However, taking large amounts over long periods can lead to high blood magnesium levels, or hypermagnesemia, which is a serious condition that can be fatal (28, 29).

Groups particularly at risk of developing hypermagnesemia include those with kidney disease, older adults with bowel disorders, and those taking 1,000 mg of magnesium oxide or more per day (28, 30).

A case series discussed four cases of hypermagnesemia, one of which was fatal. All of the patients were over 65 years old and had kidney disease (30).

As such, researchers urge healthcare professionals to be aware of this risk and monitor magnesium levels in those being treated with magnesium oxide and other forms of magnesium (30).

Magnesium oxide may also result in digestive side effects like bloating and diarrhea, especially when taken at higher doses (31, 32).

What&#;s more, the supplement may suppress the absorption of certain medications, including antipsychotic and antidepressant drugs, as well as those used to treat urinary incontinence and Parkinson&#;s disease (33, 34, 35).

If you&#;re interested in taking magnesium oxide, consult your healthcare professional to determine whether it&#;s appropriate and safe for you.

Summary

High doses of magnesium oxide may cause dangerously high blood magnesium levels, which is more likely in specific populations. It may also cause side effects like bloating and diarrhea and reduce the effectiveness of certain medications.

Dosage and how to take 

How much magnesium oxide to take depends on the treatment purpose.

For example, magnesium oxide is used to prevent migraine with daily 500-mg doses (12).

Meanwhile, 300 mg per day has been shown to help treat high blood pressure, while 250 mg per day may help lower blood sugar levels in women with gestational diabetes (23, 25).

Higher doses of the supplement &#; usually over 1 gram &#; are used to treat constipation, though daily doses as low as 250 mg may be enough for some people (5).

Summary

Magnesium oxide dosing generally ranges from 250&#;1,000 mg per day depending on what it&#;s being used to treat. Taking too much can be dangerous. Speak with your healthcare professional if you have questions regarding dosing or side effects.

The bottom line

Magnesium oxide is a form of magnesium commonly taken as a dietary supplement. It has a lower bioavailability than other forms of magnesium, but it may still offer benefits.

Mainly, it&#;s used to treat migraine and constipation. It may also help reduce blood pressure, blood sugar, and anxiety in certain populations.

Taking too much magnesium is dangerous and can cause elevated blood magnesium levels, digestive side effects, and hindered absorption of certain medications.

If you&#;re interested in supplementing with magnesium oxide, consult your healthcare professional first to find out if it&#;s the right choice for you.

The effects of nanoparticles (NPs) on the human gut microbiota are of high interest due to the link between the gut homeostasis and overall human health. The human intake of metal oxide NPs has increased due to its use in the food industry as food additives. Specifically, magnesium oxide nanoparticles (MgO-NPs) have been described as antimicrobial and antibiofilm. Therefore, in this work we investigated the effects of the food additive MgO-NPs, on the probiotic and commensal Gram-positive Lactobacillus rhamnosus GG and Bifidobacterium bifidum VPI . The physicochemical characterization showed that food additive MgO is formed by nanoparticles (MgO-NPs) and after a simulated digestion, MgO-NPs partially dissociate into Mg 2+ . Moreover, nanoparticulate structures containing magnesium were found embedded in organic material. Exposures to MgO-NPs for 4 and 24 hours increased the bacterial viability of both L. rhamnosus and B. bifidum when in biofilms but not when as planktonic cells. High doses of MgO-NPs significantly stimulated the biofilm development of L. rhamnosus, but not B. bifidum. It is likely that the effects are primarily due to the presence of ionic Mg 2+ . Evidence from the NPs characterization indicate that interactions bacteria/NPs are unfavorable as both structures are negatively charged, which would create repulsive forces.

It is worth to mention that little is known about the effects of food additive MgO-NPs on the human gastrointestinal tract and gut microbiota interface. The recently described roles that gut microbiota play in gastrointestinal function, and human health together with the increasing use of NPs in the food industry, makes this kind of studies of an urgent need. Here, we show for the first time that post in vitro digestion, the food additive MgO-NPs only partially dissociate in ions (51.2 % at intestine step), and that either (1) the size of MgO-NPs diminishes; or (2) dissociated magnesium re-precipitate forming nanoparticulate crystals of MgO or Mg(OH) 2 , which could potentially arrive to the intestinal tract, bio-accumulate and affect the gut homeostasis. However, the evidence led us to believe that the beneficial effects of food additive MgO-NPs on bacterial growth and attachment are due to the presence of dissociated Mg 2+ since the reduced presence of nanoparticulate structures and the negative charge of MgO-NPs diminishes the likelihood of bacteria/NPs interaction. Last but not least, we have demonstrated that the effects of in vitro digested food additive MgO-NPs may vary depending on the concentration, the exposure time, the bacterial mode of growth (planktonic Vs biofilms) and on the bacterial specie. Therefore, these findings highlight the importance of using physiologically relevant conditions when performing in vitro nanotoxicology as the physicochemical properties of the NPs can drastically change as well as their beneficial or detrimental effects.

In the present study, we investigated the physicochemical biotransformation of the food additive MgO in a simulated in vitro digestion model and its effects on two common commensal bacteria present in the human small intestine: Lactobacillus rhamnosus and Bifidobacterium bifidum. We extrapolated the human daily consumption of MgO to an average dose of 4.3×10 &#;4 mg mL &#;1 and considered 4.3×10 &#;3 mg mL &#;1 and 4.3×10 &#;5 mg /mL &#;1 as high and low MgO intake respectively. Planktonic and biofilm cultures of L. rhamnosus GG and B. bifidum VPI were exposed to in vitro digested MgO-NPs for a period of 4 and 24 hours and bacterial viability, adherence to surfaces and biofilm growth was quantified. Overall, our findings showed that when digested, the nanoparticulate food additive MgO partially dissociates into ionic Mg 2+ , diminishing the NPs size and concentrations. Although no detrimental effects were associated to MgO-NPs in general, different outcomes were detected based on the bacteria mode of growth (biofilms vs planktonic), bacterial species (Lactobacillus Vs Bifidobacterium), concentration, and exposure times.

To date, the effects of magnesium oxide nanoparticles (MgO-NPs) on the human GIT are poorly understood. Under biological conditions, different sized MgO complexes are formed, some within the nanometer range ( 12 ). In vivo, oral intake of MgO-NPs resulted in significant DNA damage, biochemical alterations, and oxidative stress in female Wistar rats whilst also accumulating in the liver and kidney tissues apart from urine and feces ( 13 ) 13 . Ghobadian and colleagues () reported cellular apoptosis, reactive oxygen species and malformation of zebrafish embryos exposed to MgO-NPs ( 14 ). Gelli et al., () highlighted the pulmonary toxicity that MgO-NPs produced to rats, and Mekky and coworkers () revealed elevated serum alanine aminotransferase and aspartate aminotransferase levels suggesting potential toxic effects of nano Mg on the liver tissue samples of a rat convulsion model ( 15 , 16 ). In vitro, contradictory results have been reported about the toxicity of MgO-NPs. While some authors described that exposure of various mammalian cell lines to MgO-NPs led to cytotoxic effects, such as reduced cell viability, mitochondrial and lysosomal malfunctions, DNA damage, oxidative stress, and apoptosis; Mittag et al., () indicated that MgO-NPs had no cytotoxic or genotoxic effects in intestinal HT29 cells and did not induce apoptotis, cell cycle changes, or oxidative stress ( 12 , 17 &#; 19 ). Recent studies investigated the potential applications of MgO-NPs as antimicrobial, antifungal, antibiofilm, and as biocidal for medical and agricultural purposes ( 20 &#; 22 ). MgO-NPs had been demonstrated to inhibit Gram-positive, Gram-negative, and Gram-positive endospore-forming bacteria ( 23 &#; 25 ). Moreover, Mg-ONPs (> 0.5 mg mL &#;1 ) can diminish the adhesion and biofilm formation of infectious yeast (e.g. Candida albicans and Candida glabrata) and bacterial pathogens including Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus ( 22 ). This is of particular concern, as MgO-NPs in the human GIT derived from the consumption of food supplements (e.g. MgO tablets), or food-containing E 530 could have detrimental effects on the intestinal microbiota, leading to gut dysbiosis - altering microbial diversity, abundance and functionality - which has been associated with functional gastrointestinal disorders such as irritable bowel syndrome (IBS) ( 26 ).

Magnesium oxide (MgO) is an approved food additive (E 530) used in the preparation of several food products, including milk and dairy powders, canned peas, frozen desserts, and cacao products. MgO is also widely used, in the food industry, as an anti-caking agent and flow enhancer, and its concentration is not limited except for chocolate products, which may contain up to 7% MgO relative to its dry weight ( 1 , 2 ). Due to its basic properties, MgO is particularly effective in acid neutralization and has been used as an antiacid for relief of heartburn and dyspepsia ( 3 ). Moreover, chemical grade MgO is commonly used as a short-term osmotic laxative. Orally administered MgO reacts with the gastrointestinal fluids as follows: 2HCl + MgO &#; MgCl 2 + H 2 O in the stomach, followed by MgCl 2 + 2NaHCO 3 &#; 2NaCl + Mg(HCO 3 ) 2 in the intestinal tract. Mg(HCO 3 ) 2 increases the osmotic pressure within the intestines, stimulating water exudation that softens and expands the contents of the intestines, stimulating defecation ( 4 ).

The confocal laser scanning microscope (CLSM) (LSM 880, Carl Zeiss Microscopy, LLC) equipped with an oil immersion objective (PL APO 63x/1.40 oil DIC, Carl Zeiss Microscopy, LLC) was used to visualize changes in biofilm morphology and colocalize potential NPs/bacteria interactions. Since metal oxide NPs present reflectance properties, they are easily detected using the laser 488 nm and the reflectance option of the confocal microscope (marked in bright green color by the ZEN lite software, Carl Zeiss Microscopy). The DNA of L. rhamnosus and B. bifidum were stained with DRAQ5 &#; (Thermo Fisher Scientific, USA), which allowed to visualize the bacteria in red. For further differentiation, L. rhamnosus was tagged in red, while B. bifidum was tagged in violet, artificially &#; using the color palette. For confocal imaging, only biofilms of L. rhamnosus and B. bifidum were exposed to low, medium, and high dose of food additive MgO (4.3x10 &#;3 mg mL &#;1 ) in 24-well black plates with transparent bottom. Biofilms were cultured for 4 days, scraped, and resuspended at an approximate concentration of 10 3 CFU mL &#;1 and then mixed with the NPs, which enabled standardization of cells and NPs. Following exposure to NPs, the 24-well plates were centrifuged at rpm for 5 min so that the cells clusters and the NPs would precipitate on the bottom, and to enable their visualization. Then, the samples were fixed with 4% PFA (Sigma Aldrich, Sant Louis, MO, USA) in 1x PBS for 20-30 min at room temperature (RT). After fixation, bacterial DNA was stained with DRAQ5 &#; (1:). The staining solution was incubated in the dark for 20 min at RT. Finally, the 24-well plate was left to dry. Samples were cured overnight in the dark and imaged the next day. Z Stacks image series were taken with 1 μm intervals. Overall, 4 images were taken per sample for further analysis. Overall biofilm biomass was analyzed using the ImageJ plugin COMSTAT2 ( www.comstat2.dk ).

To study the effects of food additive MgO on the ability of L. rhamnosus and B. bifidum to form biofilms, both bacterial attachment and biofilm development were assessed. For the initial attachment assay, both L. rhamnosus and B. bifidum were transferred to clear 96-well plates (Costar ® Corning Incorporated, USA) at a concentration of 10 3 CFU mL &#;1 and exposed to low (4.3×10 &#;5 mg mL &#;1 ), medium (4.3×10 &#;4 mg mL &#;1 ), and high (4.3×10 &#;3 mg mL &#;1 ) doses of MgO. The negative control was the in vitro digestion bolus with no NPs and diluted in complete BHI. Then, the attached bacteria were fixed with 4% paraformaldehyde (PFA) (Sigma Aldrich, Sant Louis, MO, USA) at room temperature for 20 min and detected and quantified after 4, 6, 12 and 24 hours by staining each well with 0.1 % of crystal violet (Sigma Aldrich, Sant Louis, MO, USA) for 15 min. The crystal violet was then removed, rinsed (4x) with deionized water, to eliminate the excess of crystal violet, and left to dry. Finally, 95% ethanol was added to each well to resuspend the attached biomass, and plates were incubated for 15 minutes on a Roto Mix (Type , Thermolyne, DE) at 200 rpm for 15 min. A plate reader (Synergy2, BioTek ® Instruments, Inc) was used to measure the plates at 570 nm absorbance ( 35 ). Similarly, since our previous studies suggested that both L. rhamnosus and B. bifidum can form biofilms that reach a steady state within a couple of days, and can be maintained for up to 6 days, the overall biomass during development were quantified using 0.1% crystal violet but at time points of 48, 72, 96, and 120 hours. Biofilm development was quantified every 24 hours because of the low growth rate of both L. rhamnosus and B. bifidum.

Bacterial viability was quantified for planktonic and biofilm cultures. For planktonic cells, overnight cultures were diluted to 10 3 CFU mL &#;1 (previously established to estimate the concentration of bacteria in the upper small intestine) and placed on 24-well plates (Costar ® Corning Incorporated, USA) using BHI (Becton, Dickinson and Company, Franklin Lakes, NJ). Bacterial cells were subsequently exposed to low (4.3×10 &#;5 mg mL &#;1 ), medium (4.3×10 &#;4 mg mL &#;1 ) and high (4.3×10 &#;3 mg mL &#;1 ) concentrations of in vitro digested MgO, previously diluted in complete BHI, for 4 h and 24 h. The negative control was the in vitro digestion bolus with no NPs and diluted in complete BHI. Following exposure, samples were homogenized, collected, serially diluted, and drop plated on the appropriate agar medium. L. rhamnosus was plated onto MRS (Becton, Dickinson and Company, Franklin Lakes, NJ) and B. bifidum onto Bifidobacterium agar plates (HIMEDIA ® Laboratories Pvt. Ltd.). Colonies were allowed to develop for a period of 48 h at 37 °C in 5% CO 2 for L. rhamnosus and at 37 °C anaerobically for B. bifidum. For biofilms, both overnight cultures were diluted to 10 3 CFU mL &#;1 , wells of 24-well plates were then inoculated. Biofilms were allowed to form for a period of 4 days before exposure to NPs. To achieve similar MgO/bacteria ratios to the planktonic experiments, 4 days biofilms were disrupted and re-inoculated at approximately 10 3 CFU mL &#;1 . Then bacterial exposure and quantification was carried out as previously stated. At least two independent biological experiments were performed using triplicate technical replicates per NP concentration exposure.

Briefly, 100 μL of each sample was pre-digested in borosilicate glass tubes with 3 mL of a concentrated ultra-pure nitric acid and perchloric acid mixture (60:40 v/v) for 16 h at room temperature. Samples were then placed in a digestion block (Martin Machine, Ivesdale, IL, USA) and heated incrementally over 4 h to a temperature of 120°C with refluxing. This step is intended to completely dissolve analytes and to decompose solids while avoiding loss of the sample and contamination. After incubation at 120°C for 2 h, 5 mL of concentrated ultra-pure nitric acid was subsequently added to each sample before raising the digestion block temperature to 145°C for an additional 2 hours. The temperature of the digestion block was then raised to 190°C and maintained for at least 10 minutes before samples were allowed to cool at room temperature. In this case, the use of nitric acid is common for metal dissolution and stabilization. Digested samples were re-suspended in 20 mL of ultrapure water prior to analysis using ICP-MS (Agilent ICP-MS Series, Agilent Technologies, Santa Clara, Ca, USA) with quality control standards (High Purity Standards, Charleston, SC, USA) following every 10 samples. Yttrium purchased from High Purity Standards (10M67-1) was used as an internal standard. To ensure batch-to-batch accuracy and to correct for matrix inference, all samples were digested and measured with 0.5 μg/mL of Yttrium (final concentration).

ICP-MS was used to quantify the amount of ionic Mg 2+ released into the medium from food additive MgO when diluted in: (i) 18 MΩ sterile DI water; (ii) BHI medium containing 0.5% of Dextrose, 0.05% of L-Cysteine and 0.1% of bacteriological agar; (iii) in vitro digestion bolus-1 (Stomach step at pH 2); and (iv) in vitro digestion bolus-2 (Intestine step at pH 7). For this, MgO was diluted as above described at the highest concentration used in this study (4.3×10 &#;3 mg mL &#;1 ). To separate the ions from the NPs, samples were centrifuged at 10,600 x g, for 10 minutes (Eppendorf Centrifuge R, with a rotor F-45-30-11, Brinkmann Instruments, Inc, Westbury, NY). The supernatant was then analyzed by ICP-MS.

In order to determine physicochemical changes of the food additive MgO during the sample preparation, the MgO NPs were characterized when dissolved in: (i) 18 MΩ sterile DI water; (ii) BHI medium containing 0.5% of Dextrose, 0.05% of L-Cysteine and 0.1% bacteriological agar; (iii) in vitro digestion bolus-1 (Stomach step at pH 2); and (iv) in vitro digestion bolus-2 (Intestine step at pH 7). Transmission electron microscopy (TEM) was then used to measure the primary particle diameter and morphology of particulate MgO. Briefly, a drop (μL) of 0.1 mg mL &#;1 of MgO suspension in 18 MΩ sterile DI water was dispensed on the top of a 400-mesh copper TEM grid (Ted Pella, Inc.) and allowed to dry. TEM images of random fields of view were acquired using a JEOL JEM-F (JEOL, Peabody, MA) and processed with Image J software to measure the diameter of approximately 100 particles. The hydrodynamic size was measured using both the Zetsizer Nano ZS90 using dynamic light scattering (DLS) and Nanosight (Malvern Panalytical Ltd) which uses the Nanoparticle Tracking Analysis software (NTA). Both DLS and NTA utilize the properties of both light scattering and Brownian motion to obtain the NP size distribution of samples in liquid suspension. The zeta potential was evaluated by laser doppler electrophoresis (LDE) using a Malvern Zetasizer Nano ZS90 (Malvern Panalytical Ltd). Sample (0.1 mg/mL) measurements were performed in Malvern disposable polycarbonate folded capillary cells with gold plated beryllium&#;copper electrodes (DTS), which were rinsed with 18 MΩ sterile DI water to clean any dust contamination before sample filling. The refractive index used for MgO was 1.73. The samples were equilibrated in the instrument chamber for 120 seconds and measured at 25°C. Three independent experiments were analyzed (n = 3).

Nanoparticles (NPs) were submitted to an in vitro digestion closely mimicking the physiology of a human digestion process. This protocol was adapted from Glahn et al., () and Moreno-Olivas et al., () ( 32 , 33 ). Briefly, after sonication MgO-NPs were mixed with 10 mL of NaCl (140 Mm) + KCl (5 mM) solution (pH=2) and adjusted to pH 2 mimicking the stomach environment. Following, 0.5 mL of pepsin solution (0.57 mM) was added to the sample. The digestion bolus was then incubated on a rocker for 1 hour at 37°C. After incubation, the pH was adjusted to 5.5-6 using NaHCO 3 (1 M). Then, pancreatin (13.3 mM )- bile (8.27 mM) solution was prepared using NaHCO 3 (0.1 M) and 2.5 mL were added to the mix adjusting the pH 7. The final volume of the digestion bolus containing MgO-NPs was adjusted to 40 mL with NaCl (140 mM)+ KCl (5mM) (pH=6.7). The in vitro digestion was performed with sterile reagents under sterile conditions. All reagents are from Sigma Aldrich (Sant Louis, MO, USA).

Food additive grade MgO-NPs were purchased from Spectrum Chemical MFG (CORP., Gardena, CA) and were prepared and dispersed using a protocol based on those established by the Organization for Economic Co-operation and Development (OECD) and the National Institute of Standards and Technology (NIST) ( 30 , 31 ). Briefly, in a 20 mL scintillation vial, 10 mg of the desired NP powder was dissolved in 10 mL of sterile 18 MΩ DI water and sonicated for 2 min at 10% amplitude and continuous mode. The probe sonicator equipped with a disruptor horn of ½&#; diameter (BRANSON Sonifier ® SFX550, Emerson Electric Co) was fully immersed in the NP suspension without touching the scintillation vial. To avoid heating the samples, the scintillation vial containing 1 mg mL &#;1 of each NP was placed in ice bath while sonicating. The disruptor horn was sterilized before and after NP preparation by sonicating a solution of 50% ethanol for 5 min.

The recommended dietary allowance is currently set at 420 mg/day for adult men and 320 mg/day for adult women ( 27 ). However, data from the National Health and Nutrition Examination Survey (NHANES) of - found that 48% of Americans of all ages ingest less magnesium from food and beverages than the estimated average required (EARs). Food additive MgO doses were calculated using the average MgO intake among users of dietary supplements (267 mg for women) ( 28 ). A total of 1.34×10 &#;4 mg cm &#;2 was established as the mean daily intake of MgO normalized to the surface area of the gastrointestinal tract (2x10 6 cm 2 ) ( 29 ). This value was shifted one order of magnitude higher and lower to mimic MgO exposure in low or deficient (1.34x10 &#;5 mg cm &#;2 ), medium or standard (1.34x10 &#;4 mg cm &#;2 ), and high or overdosed (1.34x10 &#;3 mg cm &#;2 ) doses. According to our equipment dimensions, the low, medium, and high MgO doses were estimated to be 4.3×10 &#;5 mg/mL, 4.3×10 &#;4 mg mL &#;1 , and 4.3×10 &#;3 mg mL &#;1 , respectively.

As anticipated, exposure to the food additive MgO resulted in an increase of the size of L. rhamnosus biofilm microcolonies ( ) from 4 hours to 24 hours, independently of the MgO concentration ( and ). Microcolonies of L. rhamnosus were composed of higher bacterial cell numbers, which were compacted in the center of the well, with long bacillus filaments at the edges however, no morphological differences were detected in any of the treatments. Comparing to L. rhamnosus, biofilm development of B. bifidum was slower with smaller and more compacted biofilm microcolonies ( ), further confirming the viability data ( ). Exposure of B. bifidum to high concentrations of food additive MgO resulted in larger microcolonies ( and ). Comstat analysis reinforced the trend observed in the confocal images, where the overall biomass of either L. rhamnosus and B. bifidum biofilms after 24 hours of medium and high MgO-NPs exposures was significantly higher than the control group ( Fig. S4 ).

Since both L. rhamnosus and B. bifidum biofilm derived cells were more influenced by the food additive MgO than their planktonic counterparts, confocal microscopy was once again used to detect and characterize any morphological and structural changes, as well as, to visualize biofilms/MgO-NPs interactions. Given that this study worked with physiologically relevant doses of food additive MgO, which are relatively low compared with other NP-related studies, and that MgO partially dissociate into ions, the likelihood of encountering biofilms/MgO-NPs interacting is extremely low. However, we found some as examples in (pointed with a white asterisk), where an aggregate of MgO-NPs settled on a biofilm microcolony. Further examples of interactions biofilm/MgO-NPs can be observed in the supplemental information ( Fig. S3 ). However, no differences were detected for biofilm/MgO-NPs interactions throughout the exposure time and the bacterial type.

Using the standardized crystal violet assay, we determined the attachment ability of both commensal bacteria as well as monitored the biofilm development for 5 days. The initial attachment for each species varied. L. rhamnosus showed attachment between 6 and 12 hours following the bacterial inoculum ( ), while B. bifidum needed 24- and 48-hours following inoculation ( ). Exposure of L. rhamnosus to the food additive MgO did not result in changes of bacterial attachment in the first 12 hours of biofilm development, however from 24 hours onwards high concentrations of MgO significantly stimulated biofilm development of L. rhamnosus ( ). In contrast, B. bifidum biofilms ( ) exposed to low and medium concentrations of the food additive MgO already showed a significant decrease of the overall biomass at 48 hours, compared to control. However, higher concentrations of food additive MgO significantly increased the biofilm biomass of B. bifidum after 48 hours. This trend shifted drastically after 72 hours onwards, where low and medium concentrations maintained similar levels of biofilm biomass than control, and high concentrations of food additive MgO significantly decreased the B. bifidum biomass ( ).

In this study, both L. rhamnosus and B. bifidum were exposed to digested food additive MgO for 4 hours to mimic the time for one meal to enter and exit the small intestine. It takes 3 to 5 hours from entry in the duodenum (first section of the small intestine) to exit from the ileum (last segment of the small intestine) ( 37 ). In addition, a longer exposure time (24 hours) was chosen to study the effects of putative bio-persistent MgO entrapped within the GI tract mucosa. Moreover, the effects of food additive MgO were evaluated for planktonic and biofilm derived cells. We found that exposures to low, medium, and high concentrations of in vitro digested food additive MgO did not affect the viability of planktonic cells of L. rhamnosus and B. bifidum after 4 hours ( and ) or 24 hours ( and ). However, when exposing biofilm derived cells of L. rhamnosus and B. bifidum to in vitro digested food additive MgO, significant differences in cell viability were quantified ( ). High and medium standard human intake concentrations of MgO significantly increased the viability of L. rhamnosus biofilm derived cells after 4 hours ( ) and 24 hours ( ). Similarly, viability of B. bifidum derived biofilm cells also increased significantly upon exposure to MgO at 4 hours ( ) and 24 hours ( ), albeit being in all concentrations used. Is worth to mention that (i) the initial cell density of planktonic and biofilm derived cells were standardized to 10 3 CFU mL &#;1 to enable an equal NP/bacteria ratio, and (ii) to ensure that the digestion solution by itself did not affect the cell viability (data not shown).

Because metal oxide nanoparticles have the capability of refracting polarized light, we also analyzed the food additive MgO in different suspension media using confocal laser scanning microscopy ( ). To increase the likelihood to observe MgO-NPs once we found that the NP size diminishes (by TEM), 0.5 mL of food additive MgO at a concentration of 0.25 mg mL &#;1 (stock solution) were dispensed onto a microscope slide and mounted with a coverslip. To visualize MgO-NPs we made use of a 63x objective and 488 laser. MgO-NPs suspended in water were detected ( ) and observed (bright green) to form large clusters of particulate MgO aggregating and/or agglomerating ( ). Blank samples (negative control) did not contain any refracting NPs ( ). MgO-NPs were also detected in bacterial media BHI+0.1% agar ( and ) forming NP aggregates, albeit the presence of background noise, in all the samples analyzed, most likely due to the presence of bacteriological agar ( ). However, the intensity of MgO-NPs was above background noise and clearly distinguished. Similar results were obtained when analyzing the negative controls of stomach and intestine digesta ( and ). The organic material from both stomach and intestine digesta was detected by the microscope as background noise. However, aggregates of MgO-NPs were once again detected in a higher signal (brighter green) ( and ). In agreement with the TEM and ICP-MS data, aggregates of MgO-NPs were found to be smaller when immersed in stomach conditions, suggesting that low pH triggers the MgO-NPs dissociation ( and ). Interestingly, fully digested MgO-NPs (intestine step) where detected (bright green) embedded into some background noise (red asterisk and red box), which could be the organic material present in digesta.

MgO is conventionally considered insoluble in water and stable at high temperatures. However, metal oxide nanoparticles are known to dissociate into ions when immersed in different physiologically relevant solutions ( 17 , 36 ). Therefore, we aimed to deeply understand the physicochemical changes of the food additive MgO, its potential bioavailability, and its behavior along the simulated digestion process. First, after confirming the presence of nano-crystalline structures of MgO by TEM in , we measured the ionic release of Mg 2+ from the food additive MgO-NPs in the various media suspensions. Suspensions of MgO-NPs at 4.3×10 &#;3 mg mL &#;1 in water, BHI, stomach and intestine digesta were ultracentrifuged (10,600 xg for 10 min) to separate the putative Mg 2+ ions (supernatant) from MgO-NPs (pellet) and the supernatants were analyzed by ICP-MS. The obtained results ( ) indicate that MgO-NPs partly dissociated into Mg 2+ in all the suspensions analyzed, being significantly influenced by the stomach digestion step (65.8%), followed by BHI (59.9%), intestine digestion step (51.2%), and water (39.9%). This dissociation seemed to be reversible by the pH of the intestine digestion step (51.2%) since the content of Mg 2+ in the intestinal supernatant was significantly lower than in the stomach digestion ( ). Moreover, the concentration of particles found in the stomach ( ) and intestine ( ) digestion were lower than those quantified in water ( ). Pellets of digested MgO were also analyzed by TEM to determine whether MgO-NPs were present ( and ). Despite the high complexity of both samples and the high content of organic material, crystalline structures (yellow arrows), potentially from nanoparticulate MgO, were detected by the lattice fringe effect (diffracted wave from a crystal). To confirm this, EDS analysis of the area was performed, and elemental Magnesium and Oxygen were detected in both the stomach ( ) and the intestine digestion ( ). EDS analysis did not detect Mg in controls of stomach digestion or intestine digestion lacking MgO-NPs ( Fig. S2 ). The lattice fringe effect was also observed when using TEM with NP of food additive MgO ( -indicated with a red asterisk). These findings suggest that along the human digestion, food additive MgO could partially dissociate into ions, but the remaining NP diminish its size to &#; 10 nm, further explaining the low size peaks (marked with a black asterisk) found below 100 nm when analyzing digested MgO with the Nanosight ( and ).

The food additive MgO was dispersed following OECD guidelines and subsequently submitted to an in vitro digestion - simulating the human digestion process with changes in the pH and addition of gastric enzymes. The digested MgO was then diluted to physiologically relevant concentrations in BHI before determining its effect on bacteria. Hence, food additive MgO was exposed to mechanical (peristaltic movements simulated with a rocket) and chemical (by the addition of salts, acids, and digestive enzymes) interactions that can drastically influence its physicochemical characteristics and reactivity, and consequently its interactions with live organisms, organs, tissues, and molecular structures. To understand those potential changes, we fully characterized MgO at every stage of the sample process before exposing the commensal bacteria. When analyzing the morphology of the MgO captured with TEM ( ) we found that the food additive MgO formed crystalline structures in the nanoparticle (NP) range with no defined shape or size forming aggregates and/or agglomerates. Using ImageJ, the primary particles that could be distinguished from the aggregated clusters were measured and plotted in a frequency histogram ( ). The primary particle size of MgO-NPs was found to follow a Gaussian distribution with sizes ranging from 20 to 130 nm. The average particle diameter of MgO-NPs was around 65 nm. However, when in aqueous suspension, MgO-NPs size tended to increase, mostly due to aggregation or agglomeration events ( ). The hydrodynamic distribution of MgO-NPs in water also followed a narrowed Gaussian distribution ranging from 100 to 450 nm ( ). Both the Nanosight and Nano Zetasizer were used to analyze the hydrodynamic size (d H ) of MgO-NPs in aqueous suspensions. As shown in , although both pieces of equipment use dynamic light scattering to detect and measure NPs, a large variation in MgO-NPs d H were detected for all the treatments. While Nanosight detected aggregates and/or agglomerates of MgO-NPs of approximately 208.24, 328.60, 162.36, and 193.80 nm when suspended in water, BHI+0.1% Agar, stomach and intestine digesta respectively; the Nano Zetasizer detected higher values (d H-Water = 985.14 nm; d H-BHI = .68 nm; d H-Stomach = nm; and d H-Intestine = 274.9 nm). The polydispersity index (PdI) was also measured with the Nano Zetasizer. PdI is a dimensionless value of the broadness of size distribution calculated from the cumulants analysis. Values range from 0 to 1, being <0.05 very monodisperse; <0.08 nearly monodisperse; 0.08-0.7 mid-range polydisperse; and >0.7 very polydisperse. Thus, our measurements indicate that the size range of MgO-NPs suspended in water (0.434), BHI+0.01% agar (0.56), stomach (0.993) and intestine (0.675) digesta is widespread and extremely heterogeneous, particularly in the stomach. Moreover, the NPs&#; zeta potential (ζ) (mV) and electrophoretic mobility (μm·cm/V·s) were analyzed using laser doppler electrophoresis technique (LDE), where the stability and mobility of a particle suspended in liquid is evaluated under an applied electric field. MgO-NPs were mid-range stable in water (ζ = &#;17.36 mV) and highly stable in intestine digesta (ζ = &#;41.2 mV), considering ±30 mV the reference value for a good NP stability in aqueous systems. However, in stomach digesta MgO-NPs were poorly stable (ζ = &#;2.19 mV) most likely because of the low pH (pH=2). Zeta potential measurements in more complex media such as BHI+0.1% agar (ζ = &#;.1) will be always difficult to interpret because of the viscosity of the sample. Finally, MgO-NPs seems to maintain a negatively charged particle surface through all the process independently of the media complexity and pH ( ).

4.&#;Discussion

Research from the past two decades suggest that the gastrointestinal (GI) microbiota may be linked to the homeostasis of the intestinal tract and the overall health of the human host (39). When impaired, common inflammatory and metabolic disorders including Crohn&#;s disease, ulcerative colitis; and malnutrition, type 2 diabetes, and obesity, respectively, are more likely to be developed (40,41). Environmental factors likely have a major impact on microbial dysbiosis; childbirth mode, air pollution, antibiotic use, diet, and urban environments have all previously been reported (42). Notably, the influence of diet and dietary or food-containing nanoparticles (NPs) on the intestinal microbiota and their advantageous or adverse effects are currently in the spotlight. Recent studies have reported gut microbial shifts and changes in species abundance after oral exposures to silver and titanium dioxide NPs, both used in a wide range of consumer products such as food packaging and industrial baked goods, respectively (43,44). Hence, due to the wide, and increasing use of NPs (organic and inorganic) in the food industry (food additives, food supplements or food packaging), a growing interest in studying the impacts of foodborne NPs on the intestinal microbiota has emerged. Moreover, chronic GI exposures to NPs including direct effects on microbiota and indirect effects due to NPs-mediated immune system dysfunctions, require further scrutiny. In this study, we aimed to understand the direct effects of nanoparticulate food additive MgO on the two well-studied human Gram-positive commensal bacteria L. rhamnosus GG and B. bifidum VPI . Both are early colonizers of the GI tract on newborns and of high importance, as they play a crucial role in the human gut homeostasis by preventing and fighting pathogen infections (45,46).

The main route of entry of MgO to the human body is by oral ingestion where, once ingested, the MgO will be subjected to mechanical and chemical interactions along the human digestion process. MgO presents a crystalline cubic structure and is very stable at high temperatures, which has led to conventionally classify MgO as &#;stable&#; and &#;relatively inert&#; like other metal oxides (47). However, our previous study revealed that simulated human digestion has a strong impact on metal oxide NPs&#; size and reactivity (36). Therefore, to realistically understand the impact of food additive MgO on commensal bacteria, we performed in vitro digestion of MgO and thereafter assessed its structural changes. Primary particles of the food additive MgO presented the conventional cubic structure with a mean size of 65 nm approximately, although MgO aggregated forming 200 nm particles when suspended in sterile M&#; water ( ). This tendency is commonly seen when sonicating metal oxide suspension as their surface atoms get excited and react with neighbor NPs forming ionic bounds (36). Nevertheless, the ICP-MS results showed that MgO partially dissociated in ionic Mg2+ when immersed in water, bacterial medium (completed BHI+0.01% agar), and when partially (stomach) or fully (intestine) in vitro digested ( ). These results are in agreement with those by Wetteland and co-workers (), who demonstrated that nano-sized MgO and Mg(OH)2 dissociated significantly in biologically relevant substances (DMEM, HEPES and Simulated Body Fluid) (47). Other metal oxide NPs such as SiO2 and ZnO have also been reported to partially (65.5 %) and fully (100 %) dissolve, respectively, after a simulated human digestion (48). Although biological fluids and environments are highly complex and dynamic, the impact of pH plays the most significant part in the dissociation of MgO. Other theories, like an actual nucleophilic substitution of O2&#; or OH&#; by Cl&#; (from the digestion&#;s inorganic salts), are less contemplated because the energy of Mg=O bonds is greater than that of Mg&#;Cl, making nucleophilic substitution by chloride energetically unfavorable (47,49). When measuring the hydrodynamic size of MgO suspension by dynamic light scattering, different and misleading results were obtained using Nanosight and Nano Zetasizer. While Nano Zetasizer obtained measurements of particles above nm for water, BHI and stomach digesta, Nanosight detected particles ranging from 150 to 300 nm for all the treatments ( ). It has been already discussed that DLS techniques are not well suited for complex media analysis as NPs cannot be distinguished from the other media-components such as macromolecules and proteins aggregation (SI Table 1). However, using TEM-EDX ( ) we were able to reveal the presence of crystal structures (emitting the lattice fringe effect) that contained Mg in both stomach ( ) and intestine samples ( ). These crystalline structures detected in the nanometer range are thought to be re-precipitates of MgO-NPs, precipitates of Mg(OH)2, or a hybrid of MgO with Mg(OH)2 at the particle surfaces, as magnesium could react with water (50). Contrarily, in a study where the effects of pH on MgO were studied in the absence of organic material such as gastric enzymes and inorganic salts, Schneider et al. () did not detect any nanoparticulate structure by TEM after subjecting MgO-NPs to a simulated digestion (pH, transit time and temperature) (49). Although diverse dissolution-precipitation models for MgO have been proposed in pure water and validated at certain temperatures (JMAK model), there are several parameters that can affect the aquatic chemistry (e.g. media impurities, particle size and shape, internal porosity, water acidity, CO2 content, presence of anions, etc.) and consequently interfere in the demonstration of an equilibrium model explaining the Mg re-precipitation (51). In our study, MgO samples were concentrated by ultracentrifugation to increase the chance of detecting NPs as sample volumes that can be analyzed by TEM are extremely small (10 to 20 μl). These findings were reinforced by confocal microscopy. As described in previous studies, this technique allows the detection of metal oxide NPs due to their capability to refract polarized light (using the 488 nm laser) being distinguished from other fluorescently stained structures ( ) (52). Interestingly, aggregates of NPs were seen embedded into big matrices of organic material ( ), which could completely isolate NPs from the intestinal lumen-microbiota interface and nullify its potential reactivity.

The relationship between food additive MgO-NPs and intestinal microbiota has been scarcely studied. Most previous studies have focused on the antimicrobial and antibiofilm capacity of MgO-NPs. In general, MgO-NPs showed biocidal activity against Gram-positive and Gram-negative bacteria, bacterial spores, and viruses at relatively high particle concentration (0.1 to 1.5 mg mL&#;1) (53). For example, MgO-NPs impaired biofilm formation of E. coli, Klebsiella pneumoniae and S. aureus at 0.25, 0.125 and 0.5 mg mL&#;1, respectively (20). In this study, however, we have aimed to work with physiologically relevant concentrations of food additive MgO-NPs (4.3×10&#;4 mg mL&#;1), which were extrapolated from the daily human consumption of magnesium (267 mg day&#;1). Our results show that after short-term exposures (4 and 24 hours), in vitro digested food additive MgO-NPs generally do not affect the bacterial viability of both Gram-positives L. rhamnosus and B. bifidum when growing as planktonic cells (free floating cells) ( ). However, digested MgO-NPs significantly increased the viable counts of biofilm-forming L. rhamnosus and B. bifidum already at 4 h of exposure. These results suggest that; (i) food additive MgO-NPs could be distinctly assimilated based on the bacterial mode of growth (free floating cells Vs sessile biofilm communities); and/or (ii) food additive MgO-NPs could target biofilm-specific components such as the extracellular polymeric substances (EPS). These short-term benefits were also detected in the initial bacterial attachment (from 12 to 48 hours) of both bacterial strains ( ). Despite this, differences on biofilm development between strains started appearing after 72 hours of attached biomass monitoring. While significant increments on biofilm biomass were detected for L. rhamnosus, the biofilm development of B. bifidum seemed to be significantly compromised by high and medium food additive MgO-NPs after 72, 96 and 120 hours.

In general, three main antibacterial mechanisms of NPs have been discussed: (1) mechanical interaction and consequently damage to the bacterial cell wall because of electrostatic interactions, (2) oxidative stress derived from the presence of reactive oxygen species, and (3) malfunction of proteins and extracellular structures because of metal cations release (54). In the present work, we can clearly discard the first hypothesis as the food additive MgO-NPs were negatively charged in all the four media suspensions ( ), which most likely would create electrostatic repulsions, as the bacterial cell wall and the biofilm EPS are structures also negatively charged. For the second hypothesis, Leung et al. () previously demonstrated the absence of ROS production (measured by electron spin resonance), absence of oxidative stress, and absence of lipid peroxidation after exposing the Gram-negative bacteria E. coli to 1 and 0.1 mg mL&#;1 MgO-NPs (positively charged). They found that the toxic effects of three different MgO-NPs towards E. coli resulted from cell membrane damage due to direct NP/cell wall interaction and attachment involving phosphate groups (50). Putative interaction between aggregates of food additive MgO-NPs and biofilms of L. rhamnosus and B. bifidum were detected by confocal microscopy (Fig. S3). Nevertheless, the use of physiologically relevant concentrations of MgO-NPs resulting in relatively low NPs concentration, when compared with other studies, diminishes the chance of mechanical interaction and consequently bacterial toxicity. On the other side, the release of metal cations (third hypothesis) such as Mg2+ from MgO NPs, could elucidate most of the results found along this investigation. Although metal cations such as Zn2+ and Cu2+ were seen interacting with sulfhydryl groups in enzymes, with amine and carboxyl groups on microbial cells, and causing mismetallation of proteins affecting cell metabolism ending in cell death, Mg2+ seemed to play a beneficial role when administrated in adequate amounts (55&#;58).

In bacteria, Mg2+ is the second-most abundant cation (59). The roles of Mg2+ in homeostasis, sensing and transport have been extensively investigated in Gram-negative bacteria, including Salmonella enterica and E. coli. Thus, Mg2+ was shown to act as cofactor in ATP-dependent phosphorylation in several enzymatic reactions, stabilize ribosomes and membranes, influence RNA folding and the nucleic acid-protein interactions among others (60). In Lactobacillus spp., divalent ions such as Mg2+ are also required as an essential cofactor for stimulating the activity of metalloenzymes such as aminopeptidases, dipeptidases, catalases, D-xylose isomerase, L-arabinose isomerase, and ribozymes. The addition of Mg2+ in growth media has been reported to increase growth of Lactobacillus bifermantans and L. rhamnosus FTCD (61). Similar effects were seen in cultures of B. bifidum sub-spp. pennsylvanicum, where Mg2+ deficiency markedly reduced bacterial growth and lowered the content of cellular lipid-galactose (62). These studies are in agreement with our bacterial viability results after short term exposures ( and ).

In biofilm attachment and development, the role of divalent cations such as Mg2+ appear to be multi-faceted. The presence of magnesium is thought to assist in the bacterial initial attachment to biotic or abiotic surfaces by conditioning film formation, bridging between molecules, modifying cell surface adhesins and reducing the apparent surface charge of bacteria cell wall (58). In concordance, our results showed a significant increase on initial bacterial attachment when both commensal Gram-positives L. rhamnosus (12 to 24 hours) and B. bifidum (24 to 48 hours) where exposed to high concentrations of digested food additive MgO ( ). Although not statistically significant, a similar trend of increment on initial bacterial attachment was detected when exposing both L. rhamnosus and B. bifidum to ionic Mg2+ adding MgCl2 to the cell culture medium (Fig. S5). Similarly, Hisano et al. () described that exogenous Mg2+ (0-5 mM) resulted in a higher cell to cell aggregation of Aggregatibacter actinomycetemcomitans, which positively contributes to biofilm formation (63). Mangwani et al. () also found that Ca2+ and Mg2+ (20 mM) significantly increased the average thickness, roughness coefficient and surface area of biomass of Pseudomonas mendocina biofilms (marine bacterium). Whereas Ca2+ was found to enhance the production of EPS, Mg2+ significantly increased the cell growth of P. mendocina in biofilms (64). Interestingly, exopolysaccharides extracted from Streptococcus mutants and L. rhamnosus cultures showed high binding affinity toward divalent cations (65). However, caution is needed when extrapolating the Mg2+ response of one species to another or one strain to the whole species, as it was observed in P. aeruginosa that 20 mM Mg2+ increased biofilm formation by strain PPF-1 but not by the other three strains tested (PAO1, LESB58 and Urg-7) (66). In our study, after 48 h the biofilm development of B. bifidum was significantly reduced when exposed to food additive MgO-NPs ( ), but not when exposed to MgCl2 (Fig. S5B). This could be explained by a reduced bioavailability of ionic Mg2+ when exposing B. bifidum with the food additive MgO-NPs as some Mg might be re-precipitating after long exposures forming crystalline or nanoparticulate structures. Contrarily, the study of Larsen et al. () on probiotic research, did not detect significant changes in the adhesion of Lactobacilli cells to IPEC-J2 cells in the presence of Mg2+ (67). Meanwhile, contradictory results were found in in vivo investigations. On the one hand, an in vivo study by García-Legorreta et al. (), where rats were fed with control ( mg kg&#;1), low (60 mg kg&#;1), and high ( mg kg&#;1) magnesium content diets, showed that high dietary magnesium decreased the bacterial community diversity while low dietary magnesium did not modify diversity (68). On the other hand, Winther et al. () concluded that diet deficient in magnesium modify bacterial diversity in mice contributing to the development of depressive-like behavior (69). In agreement, Pachikian et al. () found that mice with magnesium deficient diets (70 mg kg&#;1) had a lower gut bifidobacterial content (1.5 log reduction) as well as 36 to 50% lower mRNA content from components controlling the integrity of the gut barrier (zonula occludens-1, occluding, proglucagon) (70). These contradictory results reinforce the above-mentioned idea that extreme oscillations (excess or deficiency) on magnesium contents in the gut is critical for the gut homeostasis and microbiota populations, essentially commensal bacteria.

The company is the world’s best food grade/additives magnesium oxide supplier. We are your one-stop shop for all needs. Our staff are highly-specialized and will help you find the product you need.